Properties
Description
SBE13 is an CDK kinase inhibitor that disrupts cell division processes. It targets PLK1 and PLK3.
Molecular Formula
C24H27ClN2O4
Targets
PLK1: 200 pM; PLK3: 875 nM
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
SBE13 can be utilized to explore its inhibition of CHK1 and its potential to enhance the effects of radiation therapy in cancer treatment.
